IGF-1 and cardiometabolic diseases: a Mendelian randomisation study.
Susanna C LarssonKarl MichaëlssonStephen BurgessPublished in: Diabetologia (2020)
This study found evidence that increased IGF-1 levels may be causally associated with higher risk of type 2 diabetes. Graphical abstract.
Keyphrases